Plasma Modification of PCL Porous Scaffolds Fabricated by Solvent Casting/Particulate Leaching for Tissue Engineering by SARDELLA E. et al.
Plasma modification of PCL porous scaffolds fabricated by Solvent 
Casting/Particulate Leaching for Tissue Engineering 
 
F. Intranuovo1, E. Sardella2, R. Gristina2, M. Nardulli1, G. Ceccone3, P. Favia1,2,4, R. d’Agostino1,2,4
 
1Department of Chemistry, University of Bari, Italy 
2Institute of Inorganic Methodologies and Plasma (IMIP) CNR, Italy 
3European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Ispra (VA), Italy 
4Plasma Solution Srl, Spin off of the University of Bari, Italy 
 
 
Abstract: This study points out how the plasma modification of PCL porous scaffolds, 
produced by Solvent Casting/Particulate Leaching, may enhance their biocompatibility. A 
C2H4/N2 plasma deposition followed by a H2 plasma treatment was used to increase the 
hydrophilicity of the whole scaffold to support osteoblast cell proliferation, both outside 
and inside the scaffold. A better cell growth was obtained on plasma modified scaffolds. 
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1. Introduction 
 
   In recent years, Tissue Engineering has become of great 
interest and an excellent alternative to artificial prosthesis 
and organ transplant to replace diseased or damaged 
organs. This new emerging field is based on the use of 
cells seeded in a three-dimensional (3D) scaffold in order 
to reconstruct, replace, or repair living tissues and organs 
[1]. The scaffold provides the initial structural integrity 
and organizational backbone for cells to assemble into a 
functioning tissue [2]. Thus, chemical, biological and 
mechanical characteristics of a scaffold are of outmost 
importance.  
   Porous, biodegradable polymers have been found to 
play a vital role to create a suitable scaffold. It supplies 
the necessary support for cell attachment, proliferation 
and differentiation that allow a correct tissue regeneration. 
Parallel to the formation of the new tissue, the scaffold 
must undergo a biocompatible degradation [3]. 
Nowadays, there are many techniques that realize 
scaffolds with suitable biocompatibility [4-6]. Among 
them, Solvent Casting/Particulate Leaching allows the 
control of micro-structural characteristics such as 
porosity, pore size and pore interconnection degree [7]. In 
this work poly(ε-caprolactone) (PCL) scaffolds were 
produced with this technique.  
   PCL is an optimum polymer in Tissue Engineering 
applications for its good mechanical properties and 
biodegradability but its low hydrophilicity does not make 
PCL very much biocompatible and suitable for cell 
adhesion and proliferation. Thus, by controlling scaffold 
surface chemistry by a surface modification tool, it should 
be possible to control adsorption of extracellular matrix 
proteins, and, in turn, to enhance cell adhesion and 
motility [8]. Generally, when cells are seeded in vitro into 
3D scaffolds, cell adhesion is favoured at the peripheries, 
resulting in poorly populated interiors, since the external 
surfaces of the scaffolds are more accessible than the 
inner ones.  
   At present, a range of biological, physical, and chemical 
methods are used to affect surface modifications on 
biomedical devices and biomaterials. These approaches 
can be used to tune a range of properties, including 
wettability, permeability, biostability and/or chemical 
inertness, adhesion, biocompatibility, topography, 
electrical, optical and frictional characteristics. 
   Cold plasma processes can be used to tailor the surface 
composition of scaffolds. Recent advances in 
radiofrequency plasma processes (RF, 13.56 MHz) Glow 
Discharges for biomedical applications, include the 
achievement of functional surfaces for direct cell growth 
and biomolecule immobilization, the deposition of non-
fouling coatings, the deposition of nano-composite 
bacterial resistant coatings and the synthesis of nano-
structured surfaces [9]. Even though many approaches for 
the modification of the surface chemistry of polymers 
have been described, it remains an interesting challenge to 
understand their efficiency when applied to complex 3D 
structures. 
   Recent papers describe surface modification processes 
applied to scaffolds, using O2 and N2 low pressure 
plasmas [10-12] and Dielectric Barrier Discharge (DBD) 
plasmas [13,14], to promote the penetration of active 
species in the inner part of a scaffold. The use of plasma 
processes in the modification of 3D materials is a very 
interesting approach to produce cell/scaffold constructs, 
where cells are homogeneously distributed, possibly 
suitable for the reconstruction of tissues as cartilage or 
bone [15,16]. 
   The aim of this work is to show the ability of active 
species generated in low pressure RF (13.56MHz) Glow 
Discharges to modify the inside of a scaffold to render it a 
suitable support for cell seeding, albeit physical 
limitations like high Debye length and gas density, do not 
allow the ignition of low pressure glow discharges inside 
small pores. 
 
 
2. Experimental part  
 
   - Solvent Casting/Particulate Leaching process 
   PCL (Mw ~ 65,000, pellets, Aldrich) scaffolds were 
produced by means of Solvent Casting/Particulate 
Leaching technique. PCL pellets were first dissolved in 
chloroform (Fluka, 20/80 wt/wt), by stirring for about 
three hours at room temperature. To create the pores into 
the scaffold, Sodium Chloride crystals (NaCl, 
SigmaUltra) were employed as porogen, sieved to a 
specific size range (150-300 µm), added and 
homogeneously mixed to the polymer solution at different 
weight ratios (10/90, 8/92, 5/95 wt/wt). The viscous 
polymer solution was then cast in Teflon molds (10 mm 
diameter, 3 mm thickness) and dipped in ethanol (Carlo 
Erba Reagents) for about two hours at room temperature, 
to separate chloroform in a phase inversion process. The 
polymer/salt composite was then leached in bidistilled 
water for five days to remove the porogen and create 
voids into the scaffold. The resulting porosity can be 
varied in a controlled way by changing the amount of salt 
added, while the pore size is dependent on the size of the 
salt crystals. The resulting porous scaffolds were dried 
into an oven for 30 minutes and stored in a desiccator up 
to plasma treatments and/or characterization.  
 
   - Surface Modification by Plasma Deposition 
   PCL scaffolds were plasma modified in a stainless steel 
parallel-plate plasma reactor. A first 30 minutes 
deposition process was performed in a mixture of 
Ethylene/Nitrogen (C2H4/N2, 7 sccm / 21 sccm, Air 
Liquid). The pressure was set at 300 mTorr. RF 
discharges were ignited between the upper (stainless steel, 
shielded, RF connected) and the lower (grounded, sample 
holder) electrode. A RF (13.56 MHz) generator was 
utilized at 50 W of RF power in continuous (CW) mode. 
Immediately after this deposition process, scaffolds were 
plasma treated in H2 (HG 200 Hydrogen Generator) at the 
following experimental conditions: 10 sccm H2, 400 
mTorr pressure, 10 W power, 30 s time. 
 
   - SEM, XPS and WCA surface characterization 
   After the drying procedure, the scaffolds  (10 mm 
diameter, 5 mm thickness) were frozen in liquid nitrogen 
and cut, in order to obtain different sections to be 
analysed. For each sample, the surface and a horizontal 
section, cut at 3 mm of depth from the scaffold surface, 
were examined.  
   A Stereoscan 360 Cambridge Scanning Electron (60 - 
130 Pa), magnification of 70x and 250x, was used to 
examine the surface morphology (pore distribution, size 
and interconnectivity degree) of the scaffolds. 
   X-ray Photoelectron Spectroscopy (XPS) measurements 
were performed with an AXIS ULTRA Spectrometer 
(KRATOS Analytical, UK). The samples were irradiated 
with monochromatic AlKα X-rays (hν=1486.6 eV). The 
area of analysis was 400x700 μm2 and the take off angle 
(TOA) was 90° with respect to the sample surface. The 
peak fitting of the C1s spectra was done considering the 
four components of pure PCL, as shown in Figure 1, with 
the add of two other components for the plasma treated 
scaffolds: the N-C=O peak (BE 288.1 eV) and the C-N 
peak (BE 286.0 eV). 
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Fig.1: PCL chemical structure and the corresponding C1s 
fitting components. 
 
   Static Water Contact Angle (WCA) measurements were 
carried out at room temperature with a CAM200 digital 
goniometer (KSV instruments) equipped with a BASLER 
A60f camera, by using the sessile drop (2 μl) method. 
Five measures per sample were performed. WCAs were 
measured by using a micrometric syringe, perpendicular 
to the measuring plane.  
 
   - Cell culture 
   Cell culture experiments on untreated and plasma 
modified 3D scaffolds were performed with the human 
Saos2 osteoblastic cell line (ICLC). Cells were routinely 
grown in Dulbecco’s Modified Eagle Medium (DMEM, 
Sigma Chemical Co.) supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 50 IU/ml penicillin, 
50 IU/ml streptomycin and 200 mM glutamine, and kept 
at 37 ºC in a saturated humid atmosphere containing 95% 
air and 5% CO2 in 75 cm2 flasks (Iwaki, UK). Cells were 
detached with a trypsin/EDTA solution (Sigma), 
suspended in the correct medium and seeded at a 
concentration of 3x104 cells into the scaffolds placed in 1 
cm wide well of a 48 cell culture well plate (Iwaki).  
 
   - Cell proliferation assay 
   The mitochondrial activity of seeded Saos2 cells was 
determined by the MTT colorimetric assay. This test can 
detect the conversion of 3-(4,5-dimethylthiazolyl-2)-2,5-
diphenyltetrazolium bromide (Sigma) to formazan. Cells, 
after each time point, were incubated with a tenth of the 
medium of the bromide in 5% CO2 (37 ºC, 3 h) to allow 
the formation of formazan crystals. They were then 
dissolved in 10% Triton X-100 and acidic isopropanol 
(HCl 0.1N). The optical densities (O.D.) of the solutions 
were read by a spectrophotometer (Jenway 6505), at the 
wavelength of 570 nm with respect to a reference 
wavelength of 690 nm. Statistical analyses were assessed 
by the Student’s T test between samples. Differences 
were considered statistically significant for p< 0.01. 
 
 
3. Results and Discussion 
 
   - Morphological and structural properties of PCL 
scaffolds 
   Solvent Casting/Particulate Leaching, among the 
various scaffolding techniques, stands out for its 
simplicity of operation, for the possibility of producing 
scaffolds with a good pore interconnectivity degree, 
controlled composition, porosity and pore size. High 
porosity and pore interconnectivity degree and a suitable 
pore size are key parameters that permit cells to penetrate 
in depth into the scaffold, and to produce an 
homogeneous cell/scaffold construct to be used as a tissue 
substitute in a biomedical application.  
   In this study, scaffolds with 150-300 µm pore size were 
produced by using suitable sieved salt crystals. Three 
different PCL/NaCl compositions were realized (10/90, 
8/92, 5/95 wt/wt) in order to obtain scaffolds with 
different degrees of porosity. 
   According to SEM micrographs, for each scaffold 
typology, the surface and the section faces were 
topologically similar; the section was more porous and a 
better pore interconnectivity degree is visible (Figure 2). 
By varying the NaCl %, from 90 to 95%, more porous 
scaffolds were obtained.  
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Fig.2: SEM images (70x) of a scaffold (95% NaCl, 150-
300 µm pore size). Surface (left) and section (right). 
 
   - Effect of the Plasma process 
   Scaffolds with a PCL/NaCl composition of 5/95 wt/wt, 
chosen for their higher porosity among the others, were 
coated with a CxHyNz film, 548±2 nm thick, as described 
above. 
   XPS analysis attested that the scaffolds before the 
plasma treatment had a chemical composition typical of 
PCL, demonstrating that during the scaffolding process 
phases there were not any solvent and porogen residuals 
(Table 1 and Figure 3, left).  
   In order to evaluate the penetration of the plasma 
treatment in the inside of the scaffold, a XPS study in 
depth was performed. Table 1 summarizes the chemical 
composition of an untreated scaffold (A) and a plasma 
treated scaffold: surface (B) and section (C), 3 mm below 
the surface. 
   Plasma treated scaffolds exhibited a chemical 
composition completely different from the untreated ones, 
attesting for a successful modification of the material. In 
fact, Table 1 indicates the presence of  nitrogen on the 
scaffold surface and section, and an increase of the C% 
and a decrease of O% after the plasma treatment. As 
shown in Table 2 and Figure 3 (left), in the C1s spectrum 
fitting of the plasma modified scaffold, two new 
contributions appear with respect to pure PCL one (Figure 
3, right): the N-C=O peak (BE 288.1 eV) and the C-N 
peak (BE 286.0 eV), according to the presence of the N1s 
peak (6,0±0,5 N%).  
 
C% O% N% N/C O/C N/O
A 77,5
(±0,8)
22,5
(±0,8)
\ \ 0,3 \
B 82,4
(±1,5)
11,6
(±1,2)
6,0
(±0,5)
0,1 0,1 0,5
C 84,7
(±0,7)
9,7
(±1,1)
5,6
(±0,7)
0,1 0,1 0,6
 
 
Table1: C%, O% and N% of XPS wide spectra and N/C, 
O/C and N/O ratios of an untreated PCL scaffold, 95% 
NaCl, 150-300 µm pore size range (A), a plasma treated 
PCL scaffold surface (B) and a plasma treated PCL 
scaffold section, 3 mm below the surface (C). 
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Fig.3: C1s spectra of a PCL scaffold surface (95% NaCl, 
150-300 µm pore size range), the untreated (left) and the 
plasma modified one (right). 
 
//15,4
(±0,3)
19,1
(±0,4)
17,9
(±1,1)
47,6
(±1,4)
A 
C1s
C1 C2 C3 C4 C5 C6
B 52,8
(±5,7)
22,5
(±5,1)
13,5
(±1,4)
4,8
(±0,6)
3,0
(±0,5)
3,3
(±0,9)  
 
Table 2: C1s fittings of the untreated (A) and the plasma 
modified (B) PCL scaffold surface (95% NaCl, 150-300 
µm pore size range). 
 
   Observing Figure 3, there is an evident alteration of the 
C1s of PCL after the plasma treatment: the appearance of 
two nitrogen-containing peaks, the high reduction of the 
O=C-O contribution and the little increase in the 
components C1, C2 and C3 mean the formation of a 
hydrocarbon coating with C-N and amino groups on its 
surface.  
   Exciting results pointed out that the chemical 
composition, both in the external part of the scaffold and 
in its body, was very similar up to a thickness of 3 mm, 
maintaining a quite constant density of N atoms. 
   Static WCA value on PCL flat substrates was 85±2°, it 
lowered to 70±3° after the plasma deposition process. 
Further lowering of the WCA was recorded to 41±1° after 
the H2 plasma treatment, probably due to the reduction of 
N-groups to –NH2 ones in the coating, and to its exposure 
to air. WCA measures on PCL scaffolds clearly showed 
an increase in the hydrophilicity after the two plasma 
processes, obtaining a value of 77±1° with respect to 
115±1° for the untreated scaffold. These values were 
quite higher than the WCAs of flat PCL because of the 
scaffold micro-roughness. 
 
   - In vitro cell behaviour on untreated and plasma 
modified scaffolds. 
   A preliminary cell adhesion experiment was performed 
with Saos2 osteoblast cell line, a type of cells that are 
usually employed to test the biocompatibility of 3D 
scaffolds used as bone substitutes. 
   The MTT proliferation assay (Figure 4) showed that, 
after 48 hours of cell culture, osteoblast cells adhered to 
plasma modified 3D scaffolds much better than the 
untreated ones. These results confirm how the plasma 
treated scaffolds are quite promising materials for Tissue 
Engineering applications. 
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Fig.4: MTT proliferation assay on untreated (left) and 
plasma treated PCL scaffolds (right). 
 
 
4. Conclusion 
 
   In this study, a successfully plasma modification 
process was proposed to chemically modifying PCL 
scaffolds, produced by means of Solvent 
Casting/Particulate Leaching. Scaffolds with controlled 
chemical composition, porosity, pore size and a good pore 
interconnectivity degree, were obtained by this technique. 
C2H4/N2 plasma deposition followed by a H2 plasma 
treatment were used to introduce hydrophilic N-
containing groups into the PCL scaffolds, leading to 
increased wettability and better cell growth with respect 
to the untreated ones. 
   The new and surprising outcome was the excellent 
ability of the plasma treatment to penetrate into the inside 
of the scaffolds, testified by a quite constant N% in the 
chemical composition of the whole scaffold and an 
improved hydrophilicity compared to the untreated 
scaffolds. The chemical composition and wettability of 
plasma treated scaffolds evidently stimulate Saos2 
osteoblast cell growth into the plasma modified scaffolds 
compared to the untreated material. 
   Further studies are in progress to better evaluate the 
scaffold biodegradability and the cell growth/proliferation 
into the scaffolds, as a function of the plasma parameters. 
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